• Explore /
  • Poster
  • / Results of a phase Ib trial of encapsulated rapamycin in prostate cancer patients under active surveillance to prevent progression.

Results of a phase Ib trial of encapsulated rapamycin in prostate cancer patients under active surveillance to prevent progression.

Abstract Poster

Authors

null

Phillip M. Kemp Bohan

Brooke Army Medical Center, Fort Sam Houston, TX

Phillip M. Kemp Bohan, Jessica L. Cindass, Robert Connor Chick, Timothy J. Vreeland, Diane F. Hale, Annelies Hickerson, Guy Travis Clifton, George Earl Peoples, Michael Liss

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Modulating Innate Immunity

Clinical Trial Registration Number

NCT03618355

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr 34)

Abstract #

34

Poster Bd #

C11

Abstract Disclosures

Similar Posters

First Author: Jiwon Lee

First Author: David D. Chism

First Author: Gwenaelle Gravis

First Author: Eugene Shenderov